Welcome to the Knowledge Base
This respiratory knowledge base hosts in-depth videos on everything from disease and patient management, to research and development.
Select from videos below to get started.
Please refer to the full Summaries of Product Characteristics by clicking on the links above.
David Leather Salford Lung Study Key Results Asthma
David Leather Salford Lung Study Key Results COPD
Relvar Ellipta Inhaler
Why does the inhaler matter in COPD?
Professor Christine Jenkins Clinical professor, University of Sydney Department of Thoaracic Medicine, Concord Hospital Head of Respiratory Trials, The George Institute of Global Health
Experience of Anoro and patient feedback
Dr Marc Miravitlless Senior Researcher, Pneumology Department. Vall d'Hebron University Hospital, Barcelona, Spain.
Benefits of the Ellipta Inhaler
Dr Marc Miravitlles Senior Researcher, Pneumology Department. Vall d'Hebron University Hospital, Barcelona, Spain Prof. Dave Singh Professor of Clinical Pharmacology and Respiratory Medicine, University of Manchester
Adverse events should be reported directly to the HPRA; Freepost, Pharmacovigilance Section, Health Products Regulatory Authority, Earlsfort Terrace, Dublin 2, Tel: +353 1 676 4971 medsafety@hpra.ie. Adverse events should also be reported to GlaxoSmithKline on 1800 244 255.
▼ This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions.
Anoro▼, Ellipta, Incruse▼, Relvar▼ and Seretide are registered trademarks of the GlaxoSmithKline group of companies.
